Andrew R Crow
Andrew R. Crow is a Canadian scientist. He discovered the mechanism of action of intravenous immunoglobulin (IVIg) in the treatment of all autoimmune diseases.[1] Based on this discovery, his laboratory has developed new replacement therapies for IVIg. Crow has published over 15 peer reviewed papers.
Subsequently, his work in the field of medical research garnered Crow the Ontario Premier's Award for Technology in 2006.[2]
Crow graduated from Seneca College's Biological Research Technology Programme[3] in 1988, and is a Senior Research Assistant with the Canadian Blood Services,[4] located at St. Michael's Hospital.[5]
External links[edit]
- For a list of Crow's publications, see [1].
References[edit]
- ↑ Nature Medicine 12, 688 - 692 (2006); Nature Protocols 10.1038/nprot.2006.153 (2006)
- ↑ http://www.thecouncil.on.ca/files/pdfs/PremiersRecipients2006_E.pdf[permanent dead link]
- ↑ Seneca College - Toronto, Canada.- Home
- ↑ Canadian Blood Services - Société canadienne du sang
- ↑ "Archived copy". Archived from the original on 2007-10-23. Retrieved 2008-05-22.CS1 maint: Archived copy as title (link).
.svg){kind=small}   | This article about a Canadian scientist is a stub. You can help EverybodyWiki by expanding it. |
This article "Andrew R Crow" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
